Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Inspiration Healthcare Group PLC

Inspiration Healthcare Group PLC

Actions
Health CareMedical Equipment and Services
  • Price (GBX)21.10
  • Today's Change-0.40 / -1.86%
  • Shares traded25.00k
  • 1 Year change-49.76%
  • Beta0.2879
Data delayed at least 15 minutes, as of Sep 30 2024 09:37 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Inspiration Healthcare Group plc is a United Kingdom-based provider of medical technology for use in neonatal intensive care and operating theatres. The Company provides products to patients around the world which help to improve patient outcomes, and it actively invests in product opportunities and disruptive technologies. Its areas of care include Acute Care and Infusion Therapies. Its Acute Care product include neonatal, operating theaters, respiratory, auto FiO2, obstetrics and developmental care. It offers a full range of ambulatory infusion pumps, administration sets, accessories, and patient infusion management systems for both hospital and homecare applications. It provides a range of Micrel Medical infusion devices, for various applications such as parenteral nutrition, oncology, immunoglobulin therapy, antibiotic infusion, palliative care, acute pain management, and obstetrics. It is also a manufacturer of specialist pneumatic oxygen-powered life support ventilators.

  • Revenue in GBP (TTM)37.63m
  • Net income in GBP-6.03m
  • Incorporated1998
  • Employees224.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
IHC:LSE since
announced
Transaction
value
Airon CorpDeal completed04 Jan 202404 Jan 2024Deal completed-47.25%2.50m
Data delayed at least 15 minutes, as of Sep 30 2024 09:37 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Genedrive PLC272.00k-5.00m11.02m43.00--1.93--40.53-0.0407-0.04070.00220.00980.0658--1.606,325.58-120.84-97.55-197.86-128.51-----1,837.50-797.031.36-7.490.0789--12.24-50.95-10.16--16.72--
Genincode PLC2.16m-7.02m11.68m36.00--4.09--5.41-0.0732-0.07320.02250.01350.270321.883.3360,000.00-87.79---124.10--47.31---324.81--1.24--0.1883--51.05---26.21------
Renalytix PLC2.54m-34.56m15.47m80.00--0.6306--6.08-0.4231-0.42310.0310.14720.06462.884.0631,808.69-87.73-58.25-120.00-67.0320.60---1,358.30-1,904.791.71-9.620.397--14.58--18.52------
Ondine Biomedical Inc665.76k-7.98m15.93m43.00--13.50--23.92-0.0405-0.04050.00340.00510.10790.42374.74---129.24---193.37--58.44---1,198.01--1.06--0.206--88.56--25.60------
Verici DX PLC3.24m-3.60m16.06m19.00--2.23--4.96-0.0197-0.01970.01650.03040.4038--5.71231,437.90-44.82---58.12--77.06---110.99------0.0183------23.43------
Abingdon Health PLC5.34m-2.24m18.47m82.00--6.21--3.46-0.0184-0.01840.04390.01490.89787.674.7465,170.73-37.55-51.31-58.04-79.8557.3533.16-41.82-139.641.59--0.3572--42.68--83.77------
Polarean Imaging PLC1.40m-6.39m18.95m29.00--1.56--13.56-0.024-0.0240.00520.00980.10750.51091.8448,179.98-49.18-61.45-58.32-69.1744.7850.68-457.39-810.925.24--0.0093---13.75-18.2414.53--64.51--
Inspiration Healthcare Group PLC37.63m-6.03m19.73m224.00--0.5064--0.5244-0.0883-0.08830.55160.42450.72431.673.87167,991.10-11.611.04-14.181.2847.5347.61-16.041.160.9698-0.5340.307---8.7419.43-2,318.38--32.41--
Belluscura PLC617.23k-13.85m19.83m35.00--1.30--32.13-0.1049-0.10490.00470.09620.03720.30420.197517,635.00-83.37-49.84-96.68-54.78-116.54-66.07-2,243.45-1,277.341.71-3.430.00---40.9627.44-127.13--41.32--
Data as of Sep 30 2024. Currency figures normalised to Inspiration Healthcare Group PLC's reporting currency: UK Pound GBX

Institutional shareholders

60.37%Per cent of shares held by top holders
HolderShares% Held
BGF Investment Management Ltd.as of 23 Jul 202418.87m27.65%
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 May 20236.26m9.17%
Liontrust Investment Partners LLPas of 30 Jun 20244.20m6.15%
Octopus Investments Ltd.as of 30 Jun 20243.80m5.57%
Castlefield Investment Partners LLPas of 30 Jun 20242.32m3.40%
BlackRock Investment Management (UK) Ltd.as of 01 May 20242.16m3.17%
Canaccord Genuity Wealth Ltd.as of 01 May 20241.70m2.49%
Progressive Asset Management Ltd.as of 01 May 20241.05m1.54%
Hargreaves Lansdown Asset Management Ltd.as of 01 May 2024487.00k0.71%
abrdn Investment Management Ltd.as of 01 May 2024347.00k0.51%
More ▼
Data from 29 Sep 2023 - 01 Aug 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.